CG
Cadex Genomics develops molecular diagnostic tests that utilize next-generation sequencing to identify genetic mutations in tumors. These tests provide oncologists with precise information to tailor cancer treatment plans, improving patient outcomes and treatment efficacy.
Updated 4 months ago
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Cadex Genomics develops molecular diagnostic tests that utilize next-generation sequencing to identify genetic mutations in tumors. These tests provide oncologists with precise information to tailor cancer treatment plans, improving patient outcomes and treatment efficacy.